Enantiomerically pure .beta.-d-dioxolane-nucleosides

Details Enantiomerically pure .beta.-d-dioxolane-nucleosides Enantiomerically pure .beta.-d-dioxolane-nucleosides

C - Chemistry, Metallurgy

07

D

C07D 473/00 (2006.01) A61K 31/52 (2006.01) A61K 31/675 (2006.01) A61K 31/7076 (2006.01) C07F 9/6561 (2006.01)

Patent

CA 2143107

A method and composition for the treatment of humans infected with HIV that includes the administration of an HIV treatment amount of an enantiomerically pure .beta.-D-dioxolanyl purine nucleoside of formula (I), wherein R is OH, Cl, NH2, or H, or a pharmaceutically acceptable salt or derivative of the compound, optionally in a pharmaceutically acceptable carrier or diluent.

Affiliated with

Also associated with

Rating

Enantiomerically pure .beta.-d-dioxolane-nucleosides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Enantiomerically pure .beta.-d-dioxolane-nucleosides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enantiomerically pure .beta.-d-dioxolane-nucleosides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1361506